Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-15-047440
Filing Date
2015-06-24
Accepted
2015-06-24 21:38:31
Documents
2
Period of Report
2015-06-24

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 16181
2 EX-24.1 ex-24d1.htm EX-24.1 9425
  Complete submission text file 0001104659-15-047440.txt   27028
Mailing Address C/O SIRTRIS PHARMACEUTICALS, INC. 790 MEMORIAL DR. SUITE 104 CAMBRIDGE MA 02139
Business Address
Jirousek Michael (Reporting) CIK: 0001394939 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 15950496

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations